AHA, Health Organizations Express Support for S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act

AHA, health organizations letter to Senate Chairman, Lamar Alexander and Ranking Member Patty Murray, expressing support of S.2723 - The Mitigating Emergency Drug Shortages (MEDS) Act which is a holistic and sustainable approach to eliminating drugs shortages and addressing vulnerabilities in the drug supply chain.

Key Resources

Related Resources

Testimony
AHA Comments before House Committee on Ways and Means on "Examining Chronic Drug Shortages in the United States"
Public
Testimony
AHA Senate Statement on “Drug Shortages: Examining Supply Challenges, Impacts, and Policy Solutions
Public
Letter/Comment
AHA Comments on Energy and Commerce Committee's Drug Shortages Discussion Draft
Public
Letter/Comment
AHA Letter of Support for the Drug Shortage Prevention Act of 2023
Letter/Comment
AHA Responds to Request for Information on Drug Shortages
Public
AHA Center for Health Innovation Market Scan
Civica Rx Aims to Disrupt Generic Insulin Market Pricing by 2024